BCRX Cash-Secured Put Strategy

BCRX (BioCryst Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing novel, orally administered, small-molecule therapeutics. The company currently markets two key products: Peramivir injection: An intravenous neuraminidase inhibitor, sold under the brand names RAPIVAB, RAPIACTA, and PERAMIFLU, used for the treatment of acute uncomplicated influenza. ORLADEYO: An oral serine protease inhibitor designed to manage hereditary angioedema. BioCryst's development pipeline includes several promising candidates: BCX9930: An oral factor D inhibitor in Phase II clinical trials for complement-mediated diseases. BCX9250: An oral activin receptor-like kinase-2 inhibitor undergoing Phase I clinical evaluation for fibrodysplasia ossificans progressiva. Galidesivir: An RNA dependent-RNA polymerase inhibitor, also in Phase I, aimed at treating a range of RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika.

BCRX (BioCryst Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.09B, a beta of 0.57 versus the broader market, a 52-week range of 6-10.94, average daily share volume of 4.9M, a public-listing history dating back to 1994, approximately 580 full-time employees. These structural characteristics shape how BCRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.57 indicates BCRX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a cash-secured put on BCRX?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current BCRX snapshot

As of June 29, 2026, spot at $9.54, ATM IV 73.90%, IV rank 27.22%, expected move 21.19%. The cash-secured put on BCRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this cash-secured put structure on BCRX specifically: BCRX IV at 73.90% is on the cheap side of its 1-year range, which means a premium-selling BCRX cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 21.19% (roughly $2.02 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BCRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on BCRX should anchor to the underlying notional of $9.54 per share and to the trader's directional view on BCRX stock.

BCRX cash-secured put setup

The BCRX cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BCRX near $9.54, the first option leg uses a $9.06 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BCRX chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BCRX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$9.06N/A

BCRX cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

BCRX cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on BCRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on BCRX

Cash-secured puts on BCRX earn premium while a trader waits to acquire BCRX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning BCRX.

BCRX thesis for this cash-secured put

The market-implied 1-standard-deviation range for BCRX extends from approximately $7.52 on the downside to $11.56 on the upside. A BCRX cash-secured put lets a trader earn premium while waiting to acquire BCRX at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current BCRX IV rank near 27.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BCRX at 73.90%. As a Healthcare name, BCRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BCRX-specific events.

BCRX cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BCRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BCRX alongside the broader basket even when BCRX-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on BCRX carry tail risk when realized volatility exceeds the implied move; review historical BCRX earnings reactions and macro stress periods before sizing. Always rebuild the position from current BCRX chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on BCRX?
A cash-secured put on BCRX is the cash-secured put strategy applied to BCRX (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With BCRX stock trading near $9.54, the strikes shown on this page are snapped to the nearest listed BCRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are BCRX cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the BCRX cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 73.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a BCRX cash-secured put?
The breakeven for the BCRX cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BCRX market-implied 1-standard-deviation expected move is approximately 21.19%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on BCRX?
Cash-secured puts on BCRX earn premium while a trader waits to acquire BCRX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning BCRX.
How does current BCRX implied volatility affect this cash-secured put?
BCRX ATM IV is at 73.90% with IV rank near 27.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related BCRX analysis